Share on

North America Oligonucleotide Synthesis Market - By Product, End-User & Region - Industry Analysis on Size, Share, Trends, Growth & Forecast Report | (2023-2028)

Published: March, 2023
ID: 9290
Pages: 145
Formats: report pdf report excel report power bi report ppt

North America Oligonucleotide Synthesis Market Size 2023-2028

North America Oligonucleotide Synthesis Market accounts for the most substantial market share in the world. It is likely to progress with a CAGR of 13.4% in the outlook period between 2023-2028

Impact of COVID-19 on the North America Oligonucleotide Synthesis Market:

North America, especially the USA is the hotspot for the Covid-19 virus with infection rates surging every week. Amidst this, the economies have contracted by 25% and it has an adverse effect on every sector. However, the oligonucleotide synthesis market saw an increase in demand during this period as clinical trials for vaccines were going on, and the search for a foolproof vaccine was in full swing. A lot of investments are being made in the pharmaceutical and healthcare sectors which is likely to boost the growth of the regional oligonucleotide synthesis market.

North America Oligonucleotide Synthesis Market Recent Developments in the Industry:

  • In February 2019, Thermo Fisher Scientific reached an agreement with BioNTech a German company, under the terms that BioNTech's messenger RNA (mRNA) manufacturing platform will be supported by Thermo Fisher through the supply of enzymes, nucleotides, and other core components.
  • Danaher purchased IDT and increased its courier zones of cost-free succeeding day delivery service to scientists in the cities of Cambridge, Oxford, and London. This service expansion will help IDT to increase its customer base, and also enable the starting and ending of a project sooner.

Drivers and Restraints of the North America Oligonucleotide Synthesis Market

North America is a hub for various production industries and construction, and the growth of the oligonucleotide synthesis market is primarily because of the various research and development activities taking part in North America, particularly in the nations like USA and Canada. This growth in the industry can also be attributed to the developments in the healthcare sector. Initiatives such as the vaccine for children and the prevention of HIV/AIDS have contributed a lot.Covid-19 has had a significant impact on end-users like the construction and production segments. All the activities have come to a halt. On top of this, the oligonucleotide synthesis process is very expensive. This cost ineffectiveness may likely be a factor that may hinder business growth.

Market Segmentation:

North America Oligonucleotide Synthesis Market-On the Basis of the Product

  • Primers

  • Probes

  • Linkers

  • Adaptors

  • Custom

  • Reagent

  • Equipment

North America Oligonucleotide Synthesis Market-On the Basis of the Application:

  • DNA

  • PCR

  • RNAi

  • Research

  • Therapeutics

North America Oligonucleotide Synthesis Market-On the Basis of End-Use:

  • Biotechnology

  • Pharmaceutical

  • Academic

The pharmaceutical segment accounted for the largest share of the Oligonucleotide Synthesis market. They also contribute to the highest revenue generated compared to other end-user segments. Oligonucleotide-based drugs have also shown promising growth in the past few years and with the development of healthcare, more investments are likely to follow in this segment. These synthetic products are also in high demand from academic and research institutes are more investments are being made in clinical trials.

North America Oligonucleotide Synthesis Market Regional Analysis:

Clinical trials in Canada for investigational therapy are likely to promote the market for oligonucleotide synthesis in the North American region.

The United States is expected to be the leader of the market in the North America area owing to its increasing investments and rising funds dedicated to manufacturing companies as well as academic and research institutes for the research and development of gene synthesis-based end products that include precision medicine and other therapeutics.

Key Players:

  • Agilent Technologies
  • Bio Synthesis Inc.
  • Bio Automation Corporation
  • Biogen International
  • GE Healthcare
  • Trilink Biotechnologies

Please wait. . . . Your request is being processed

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample